Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Sealing capability and marginal fit of titanium versus zirconia abutments with different connection designs.

Şen N, Şermet IB, Gürler N.

J Adv Prosthodont. 2019 Apr;11(2):105-111. doi: 10.4047/jap.2019.11.2.105. Epub 2019 Apr 26.

2.

Effect of coloring and sintering on the translucency and biaxial strength of monolithic zirconia.

Sen N, Sermet IB, Cinar S.

J Prosthet Dent. 2018 Feb;119(2):308.e1-308.e7. doi: 10.1016/j.prosdent.2017.08.013. Epub 2017 Nov 15.

PMID:
29150133
3.

Lung transplantation in childhood and adolescence: unicentric 14-year experience with sex matching as the main prognosticator.

Mangiameli G, Arame A, Boussaud V, Petitti T, Rivera C, Pricopi C, Badia A, Achouh P, Legras A, Guillemain R, Riquet M, Cholley B, Sermet I, Le Pimpec Barthes F.

Eur J Cardiothorac Surg. 2016 Mar;49(3):810-7. doi: 10.1093/ejcts/ezv243. Epub 2015 Jul 16.

PMID:
26188011
4.

Is the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis?

Matecki S, Kent L, de Boeck K, Le Bourgeois M, Zielen S, Braggion C, Arets HG, Bradley J, Davis S, Sermet I, Reix P; respiratory function group of the European Cystic Fibrosis Society Clinical Trial Network.

J Cyst Fibros. 2016 Jan;15(1):10-20. doi: 10.1016/j.jcf.2015.03.015. Epub 2015 Apr 15. Review.

5.

Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.

Roux AL, Catherinot E, Soismier N, Heym B, Bellis G, Lemonnier L, Chiron R, Fauroux B, Le Bourgeois M, Munck A, Pin I, Sermet I, Gutierrez C, Véziris N, Jarlier V, Cambau E, Herrmann JL, Guillemot D, Gaillard JL; OMA group.

J Cyst Fibros. 2015 Jan;14(1):63-9. doi: 10.1016/j.jcf.2014.07.004. Epub 2014 Jul 30.

6.

Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.

Saussereau E, Vachier I, Chiron R, Godbert B, Sermet I, Dufour N, Pirnay JP, De Vos D, Carrié F, Molinari N, Debarbieux L.

Clin Microbiol Infect. 2014 Dec;20(12):O983-90. doi: 10.1111/1469-0691.12712. Epub 2014 Jul 26.

7.

Lung clearance index: evidence for use in clinical trials in cystic fibrosis.

Kent L, Reix P, Innes JA, Zielen S, Le Bourgeois M, Braggion C, Lever S, Arets HG, Brownlee K, Bradley JM, Bayfield K, O'Neill K, Savi D, Bilton D, Lindblad A, Davies JC, Sermet I, De Boeck K; European Cystic Fibrosis Society Clinical Trial Network (ECFS-CTN) Standardisation Committee.

J Cyst Fibros. 2014 Mar;13(2):123-38. doi: 10.1016/j.jcf.2013.09.005. Epub 2013 Dec 5. Review.

8.

Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis.

Fayon M, Kent L, Bui S, Dupont L, Sermet I; European Cystic Fibrosis Society Clinical Trial Network Standardisation Committee.

Eur Respir J. 2014 Feb;43(2):610-26. doi: 10.1183/09031936.00017713. Epub 2013 Jul 11. Review.

9.

Influence of perfusate temperature on nasal potential difference.

Bronsveld I, Vermeulen F, Sands D, Leal T, Leonard A, Melotti P, Yaakov Y, de Nooijer R, De Boeck K, Sermet I, Wilschanski M, Middleton PG; European Cystic Fibrosis Society – Diagnostic Network Working Group.

Eur Respir J. 2013 Aug;42(2):389-93. doi: 10.1183/09031936.00097712. Epub 2012 Oct 25.

10.

Nasal polyposis and cystic fibrosis(CF): review of the literature.

Feuillet-Fieux MN, Lenoir G, Sermet I, Elie C, Djadi-Prat J, Ferrec M, Magen M, Couloigner V, Manach Y, Lacour B, Bonnefont JP.

Rhinology. 2011 Aug;49(3):347-55. doi: 10.4193/Rhino10.225. Review.

PMID:
21858268
11.

Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN).

De Boeck K, Bulteel V, Tiddens H, Wagner T, Fajac I, Conway S, Dufour F, Smyth AR, Lee T, Sermet I, Kassai B, Elborn S; ECFS-CTN network partners.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S67-74. doi: 10.1016/S1569-1993(11)60010-6.

12.

New clinical diagnostic procedures for cystic fibrosis in Europe.

De Boeck K, Derichs N, Fajac I, de Jonge HR, Bronsveld I, Sermet I, Vermeulen F, Sheppard DN, Cuppens H, Hug M, Melotti P, Middleton PG, Wilschanski M; ECFS Diagnostic Network Working Group; EuroCareCF WP3 Group on CF diagnosis.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S53-66. doi: 10.1016/S1569-1993(11)60009-X. Review.

13.

Recommendations for the classification of diseases as CFTR-related disorders.

Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, Sermet I, Schwarz M, Tzetis M, Wilschanski M, Bareil C, Bilton D, Castellani C, Cuppens H, Cutting GR, Drevínek P, Farrell P, Elborn JS, Jarvi K, Kerem B, Kerem E, Knowles M, Macek M Jr, Munck A, Radojkovic D, Seia M, Sheppard DN, Southern KW, Stuhrmann M, Tullis E, Zielenski J, Pignatti PF, Ferec C.

J Cyst Fibros. 2011 Jun;10 Suppl 2:S86-102. doi: 10.1016/S1569-1993(11)60014-3.

14.

Pharmacokinetics and diffusion into sputum of oseltamivir and oseltamivir carboxylate in adults with cystic fibrosis.

Jullien V, Hubert D, Launay O, Babany G, Lortholary O, Sermet I.

Antimicrob Agents Chemother. 2011 Sep;55(9):4183-7. doi: 10.1128/AAC.00371-11. Epub 2011 Jun 13.

15.

Urgent lung transplantation in cystic fibrosis patients: experience of a French center.

Saueressig MG, Pelluau S, Sermet I, Souilamas R.

Eur J Cardiothorac Surg. 2011 Sep;40(3):e101-6. doi: 10.1016/j.ejcts.2011.04.013. Epub 2011 May 26.

PMID:
21616676
16.

[Fungal infections in cystic fibrosis].

Le Bourgeois M, Sermet I, Bailly-Botuha C, Delacourt C, de Blic J.

Arch Pediatr. 2011 May;18 Suppl 1:S15-21. doi: 10.1016/S0929-693X(11)70936-8. French.

PMID:
21596282
17.

Suboptimal ciprofloxacin dosing as a potential cause of decreased Pseudomonas aeruginosa susceptibility in children with cystic fibrosis.

Guillot E, Sermet I, Ferroni A, Chhun S, Pons G, Zahar JR, Jullien V.

Pharmacotherapy. 2010 Dec;30(12):1252-8. doi: 10.1592/phco.30.12.1252.

PMID:
21114393
18.

Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS.

Houwen RH, van der Doef HP, Sermet I, Munck A, Hauser B, Walkowiak J, Robberecht E, Colombo C, Sinaasappel M, Wilschanski M; ESPGHAN Cystic Fibrosis Working Group.

J Pediatr Gastroenterol Nutr. 2010 Jan;50(1):38-42. doi: 10.1097/MPG.0b013e3181a6e01d.

PMID:
19525866
19.

Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.

Goubau C, Wilschanski M, Skalická V, Lebecque P, Southern KW, Sermet I, Munck A, Derichs N, Middleton PG, Hjelte L, Padoan R, Vasar M, De Boeck K.

Thorax. 2009 Aug;64(8):683-91. doi: 10.1136/thx.2008.104752. Epub 2009 Mar 23.

PMID:
19318346
20.

Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments.

Hubert D, Aubourg F, Fauroux B, Trinquart L, Sermet I, Lenoir G, Clément A, Dinh-Xuan AT, Louis B, Mahut B, Delclaux C.

Eur Respir J. 2009 Jul;34(1):117-24. doi: 10.1183/09031936.00164508. Epub 2009 Feb 12.

21.

Glutathione S-transferases related to P. aeruginosa lung infection in cystic fibrosis children: preliminary study.

Feuillet-Fieux MN, Nguyen-Khoa T, Loriot MA, Kelly M, de Villartay P, Sermet I, Verrier P, Bonnefont JP, Beaune P, Lenoir G, Lacour B.

Clin Biochem. 2009 Jan;42(1-2):57-63. doi: 10.1016/j.clinbiochem.2008.09.116. Epub 2008 Oct 17.

PMID:
18976645
22.

A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis.

Mayell SJ, Munck A, Craig JV, Sermet I, Brownlee KG, Schwarz MJ, Castellani C, Southern KW; European Cystic Fibrosis Society Neonatal Screening Working Group.

J Cyst Fibros. 2009 Jan;8(1):71-8. doi: 10.1016/j.jcf.2008.09.005. Epub 2008 Oct 28.

23.

[Potential nasal transepithelial difference].

Fajac I, Sermet I.

Rev Pneumol Clin. 2008 Feb;64(1):34-7. Review. French. No abstract available.

PMID:
18613347
24.

Glucose tolerance and insulin secretion, morbidity, and death in patients with cystic fibrosis.

Bismuth E, Laborde K, Taupin P, Velho G, Ribault V, Jennane F, Grasset E, Sermet I, de Blic J, Lenoir G, Robert JJ.

J Pediatr. 2008 Apr;152(4):540-5, 545.e1. doi: 10.1016/j.jpeds.2007.09.025. Epub 2007 Nov 26.

PMID:
18346512
25.

[Cervical tumefaction in a teenager with cystic fibrosis].

Vrielynck S, Roques C, Sermet I, Emond S, Lenoir G.

Arch Pediatr. 2007 Oct;14(10):1210-2. Epub 2007 Jul 12. French.

PMID:
17628456
26.

A new large CFTR rearrangement illustrates the importance of searching for complex alleles.

Niel F, Legendre M, Bienvenu T, Bieth E, Lalau G, Sermet I, Bondeux D, Boukari R, Derelle J, Levy P, Ruszniewski P, Martin J, Costa C, Goossens M, Girodon E.

Hum Mutat. 2006 Jul;27(7):716-7.

PMID:
16786510
27.

[Cystic fibrosis: chemical drugs to cure genetic diseases].

Lallemand JY, Leclaire B, Sermet I, Lenoir G.

Bull Acad Natl Med. 2005 May;189(5):789-95; discussion 795-6. French.

PMID:
16433451
28.

SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.

Bergwitz C, Roslin NM, Tieder M, Loredo-Osti JC, Bastepe M, Abu-Zahra H, Frappier D, Burkett K, Carpenter TO, Anderson D, Garabedian M, Sermet I, Fujiwara TM, Morgan K, Tenenhouse HS, Juppner H.

Am J Hum Genet. 2006 Feb;78(2):179-92. Epub 2005 Dec 9.

29.

Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients.

Munck A, Malbezin S, Bloch J, Gerardin M, Lebourgeois M, Derelle J, Bremont F, Sermet I, Munck MR, Navarro J.

Eur Respir J. 2004 Mar;23(3):430-4.

30.

Novel CFTR mutations in black cystic fibrosis patients.

Feuillet-Fieux MN, Ferrec M, Gigarel N, Thuillier L, Sermet I, Steffann J, Lenoir G, Bonnefont JP.

Clin Genet. 2004 Apr;65(4):284-7.

PMID:
15025720
31.

Clinical variability and genetic homogeneity of the camptodactyly-arthropathy-coxa vara-pericarditis syndrome.

Faivre L, Prieur AM, Le Merrer M, Hayem F, Penet C, Woo P, Hofer M, Dagoneau N, Sermet I, Munnich A, Cormier-Daire V.

Am J Med Genet. 2000 Nov 27;95(3):233-6.

PMID:
11102929
32.

Identification of a novel mutation, 1087delT, in exon 7 of the CFTR gene in a patient with cystic fibrosis.

Feuillet-Fieux MN, Sermet I, Edelman A, Torossi T, Ferrec M, Guillot M, Lenoir G, Bonnefont JP, Thuillier L.

Hum Mutat. 2000 Jul;16(1):95. No abstract available.

PMID:
10874326

Supplemental Content

Loading ...
Support Center